Megestrol Acetate is named as a drug or biological intervention in 6 clinical trials in our China trial register, 4 of which are recruiting. Lead sponsors include Women's Hospital School Of Medicine Zhejiang University (1), Fudan University (1) and Changchun GeneScience Pharmaceutical Co., Ltd. (1). Registered phases: Phase 2/3, Not applicable, Phase 1, Phase 3 and Phase 2. Conditions studied include Endometrial Cancer Stage I; Endometrial Hyperplasia; Endometrial Cancer.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Endometrial Cancer Stage I | 1 |
| Endometrial Hyperplasia | 1 |
| Endometrial Cancer | 1 |
| Fertility | 1 |
| Efficacy | 1 |
| Safety | 1 |
| Megestrol Acetate | 1 |
| Adult Subject | 1 |
| Neoadjuvant Chemotherapy | 1 |
| Weight Loss | 1 |
| Atypical Endometrial Hyperplasia | 1 |
| Fertility Issues | 1 |
| Overweight and Obesity | 1 |
| Stage III Gastric Cancer | 1 |
| Lead sponsor | Trials |
|---|---|
| Women's Hospital School Of Medicine Zhejiang University | 1 |
| Fudan University | 1 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 1 |
| Xiaojun Chen | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Register | Megestrol Acetate trials |
|---|---|
| Clinical trials in China | 6 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Megestrol Acetate works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Megestrol Acetate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.